|
RNF214 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.34659999995179E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.71919999994541E-06 |
| Normal-vs-Stage2 |
3.388400E-01 |
| Normal-vs-Stage3 |
1.646780E-04 |
| Normal-vs-Stage4 |
1.26600000005528E-06 |
| Stage1-vs-Stage2 |
1.289370E-01 |
| Stage1-vs-Stage3 |
2.621400E-01 |
| Stage1-vs-Stage4 |
1.005230E-01 |
| Stage2-vs-Stage3 |
7.582500E-02 |
| Stage2-vs-Stage4 |
1.729550E-02 |
| Stage3-vs-Stage4 |
4.148600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.20330000000324E-06 |
| Normal-vs-AfricanAmerican |
4.763500E-04 |
| Normal-vs-Asian |
2.827600E-04 |
| Caucasian-vs-AfricanAmerican |
9.323600E-01 |
| Caucasian-vs-Asian |
2.943600E-01 |
| AfricanAmerican-vs-Asian |
3.180600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.29339999716183E-08 |
| Normal-vs-Female |
1.174250E-01 |
| Male-vs-Female |
2.681200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.448000E-04 |
| Normal-vs-Extreme_Weight |
3.89909999842786E-08 |
| Normal-vs-Obese |
3.338400E-03 |
| Normal-vs-Extreme_Obese |
6.602500E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.805000E-01 |
| Normal_Weight-vs-Obese |
5.387400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.493600E-01 |
| Extreme_Weight-vs-Obese |
6.828500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.680000E-01 |
| Obese-vs-Extreme_Obese |
6.784000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.134000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.397400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.00389999979633E-07 |
| Normal-vs-Age(81-100Yrs) |
7.54790000000449E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.645200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.262400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.529800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.441700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.603570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.926800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.43430000005318E-07 |
| Normal-VS-Type2 PRCC |
3.76499999998892E-06 |
| Normal-VS-KIRP CIMP |
3.768200E-01 |
| Normal-VS-Unclassified PRCC |
1.296820E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.917200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.665200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.144200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.402200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.509780E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.441200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.39679999969722E-07 |
| Normal-vs-N1 |
4.440100E-03 |
| Normal-vs-N2 |
5.7285000000018E-05 |
| N0-vs-N1 |
8.690800E-01 |
| N0-vs-N2 |
1.798650E-01 |
| N1-vs-N2 |
4.903900E-02 |
|
|
